3[1]Baldessarini RJ,Tarazi FI.Drugs and the treatment of psychiatric disorders:Antipsychotic and antimanic agents.In:Hardman JG,Limbird LE,Gilman AG,editors.Goodman and Gilman's the pharmacological basis of therapeutics[M].10th ed.New York:McGraw-Hill Press;2001:485.
4[2]Tuunainen A,Wahlbeck K,Gilbody SM.Newer atypical antipsychotic medication versus clozapine for schizophrenia[J].Cochrane Database Syst Rev,2000,(2):CD000966.
5[3]Addington DE,Pantelis C,Dineen M,et al.Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder:an 8-week,double-blind,multicenter trial[J].J Clin Psychiatry,2004,65:1624.
7[5]Moller HJ.Management of the negative symptoms of schizophrenia:new treatment options[J].CNS Drugs,2003,17:793.
8[6]Coe R.What is an effect size:a guide for users.Durham(UK):Evidence-Based Education UK[EB/OL].Available:www.cemcentre.org/ebeuk/research/effectsize/ESguide.htm(accessed 2005 5 19).
9[7]Bilder RM,Goldman RS,Volavka J,et al.Neurocognitive effects of clozapine,olanzapine,risperidone,and haloperidol in patients with chronic schizophrenia or schizoaffective disorder[J].Am J Psychiatry,2002,159:1018.
10[8]Keefe RS,Seidman LJ,Christensen BK,et al.Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis:a randomized,double-blind trial of olanzapine versus low doses of haloperidol[J].Am J Psychiatry,2004,161:985.
